Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)
(B(Released by National Health Commission & National Administration of Traditional Chinese Medicine on March 3, 2020)PWPei-Fang Wei
Indexed incrossrefdoajpubmed
Abstract
Since December 2019, multiple cases of novel coronavirus pneumonia (COVID-19) have been identified in Wuhan, Hubei. With the spread of the epidemic, such cases have also been found in other parts of China and other countries. As an acute respiratory infectious disease, COVID-19 has been included in Class B infectious diseases prescribed in the Law of the People's Republic of China on Prevention and Treatment of Infectious Diseases, and managed as an infectious disease of Class A. By taking a series of preventive control and medical treatment measures, the rise of the epidemic situation in China has been contained to a certain extent, and the epidemic situation has eased in most provinces, but the incidence…
Citation impact
814
total citations
- FWCI
- 84.69
- Percentile
- 100%
- References
- 0
Citations per year
Authors
2Topics & keywords
Keywords
- Medicine
- Pneumonia
- Coronavirus
- Outbreak
- Disease
- Infectious disease (medical specialty)
- Etiology
- Clinical trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.